share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

SEC ·  Jun 22 04:28

Summary by Futu AI

On June 18, 2024, James F. Young, associated with Novavax Inc [NVAX], completed the sale of 7,500 shares of common stock in two separate transactions. The first transaction involved the sale of 6,393 shares at a price of $13.62 per share, while the second saw 1,107 shares sold at $14.28 each. Following these transactions, Young holds a total of 69,260 Novavax shares. The total market value of the disposed shares amounted to $102,880.62. These sales were executed as open market or private sales and are part of Young's direct holdings.
On June 18, 2024, James F. Young, associated with Novavax Inc [NVAX], completed the sale of 7,500 shares of common stock in two separate transactions. The first transaction involved the sale of 6,393 shares at a price of $13.62 per share, while the second saw 1,107 shares sold at $14.28 each. Following these transactions, Young holds a total of 69,260 Novavax shares. The total market value of the disposed shares amounted to $102,880.62. These sales were executed as open market or private sales and are part of Young's direct holdings.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.